80 related articles for article (PubMed ID: 7204968)
1. Sex-related differences in the rapid production of cytotoxic spleen cells active against uninfected myofibers during Coxsackievirus B-3 infection.
Huber SA; Job LP; Auld KR; Woodruff JF
J Immunol; 1981 Apr; 126(4):1336-40. PubMed ID: 7204968
[TBL] [Abstract][Full Text] [Related]
2. Generation of cytotoxic T lymphocytes during coxsackievirus tb-3 infection. II. Characterization of effector cells and demonstration cytotoxicity against viral-infected myofibers1.
Wong CY; Woodruff JJ; Woodruff JF
J Immunol; 1977 Apr; 118(4):1165-9. PubMed ID: 300400
[TBL] [Abstract][Full Text] [Related]
3. Generation of cytotoxic T lymphocytes during coxsackievirus B-3 infection. I. Model and viral specificity1.
Wong CY; Woodruff JJ; Woodruff JF
J Immunol; 1977 Apr; 118(4):1159-64. PubMed ID: 300399
[TBL] [Abstract][Full Text] [Related]
4. Studies on natural killer (NK) cells. III. The effects of in vitro culture on spontaneous cytotoxicity of murine spleen cells.
Bartlett SP; Burton RC
J Immunol; 1982 Mar; 128(3):1070-5. PubMed ID: 7057032
[TBL] [Abstract][Full Text] [Related]
5. Lysis of infected myofibers by coxsackievirus B-3-immune T lymphocytes.
Huber SA; Job LP; Woodruff JF
Am J Pathol; 1980 Mar; 98(3):681-94. PubMed ID: 6244737
[TBL] [Abstract][Full Text] [Related]
6. Generation of cytotoxic T lymphocytes during coxsackievirus B-3 infection. III. Role of sex.
Wong CY; Woodruff JJ; Woodruff JF
J Immunol; 1977 Aug; 119(2):591-7. PubMed ID: 301899
[No Abstract] [Full Text] [Related]
7. Sex-related differences in the pattern of coxsackievirus B-3-induced immune spleen cell cytotoxicity against virus-infected myofibers.
Huber SA; Job LP; Woodruff JF
Infect Immun; 1981 Apr; 32(1):68-73. PubMed ID: 6260687
[TBL] [Abstract][Full Text] [Related]
8. Effects of B4 Coxsackievirus infection on cell-mediated immunity, natural cytotoxicity and interleukin-1 production by spleen cells, in mice.
Voiculescu C; Rogoz S; Roşu L; Medeşan C; Olinescu A
Rev Roum Virol; 1990; 41(1):53-60. PubMed ID: 2171627
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
[TBL] [Abstract][Full Text] [Related]
10. [TH1 response in the experimental infection with Trypanosoma cruzi].
Cardoni RL; Antúnez MI; Abrami AA
Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
[TBL] [Abstract][Full Text] [Related]
11. Studies on the mechanism of natural killer (NK) cell-mediated cytotoxicity (CMC). I. Release of cytotoxic factors specific for NK-sensitive target cells (NKCF) during co-culture of NK effector cells with NK target cells.
Wright SC; Bonavida B
J Immunol; 1982 Jul; 129(1):433-9. PubMed ID: 7086139
[No Abstract] [Full Text] [Related]
12. Studies on natural killer (NK) cells. I. NK cell specific antibodies in CE anti-CBA serum.
Burton RC; Winn HJ
J Immunol; 1981 May; 126(5):1985-9. PubMed ID: 7217676
[TBL] [Abstract][Full Text] [Related]
13. In vivo activation of natural killer cells and priming of IL-2 responsive cytolytic cells by loxoribine (7-allyl-8-oxoguanosine).
Pope BL; Chourmouzis E; Sigindere J; MacIntyre JP; Capetola RJ; Lau CY
Cell Immunol; 1993 Apr; 147(2):302-12. PubMed ID: 8453674
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-2 (IL-2) activated natural killer (A-NK) cells: binding to microvascular endothelial cells and BRM enhancement of cytolytic activity.
Brunson KW; Ohashi M; Miller CA; Kitson RP; Basse PH; Goldfarb RH
In Vivo; 1994; 8(1):71-5. PubMed ID: 8054514
[TBL] [Abstract][Full Text] [Related]
15. Prevention of lethal graft-versus-host disease in mice by monoclonal antibodies directed against T cells or their subsets. I. Evidence for the induction of a state of tolerance based on suppression.
Knulst AC; Tibbe GJ; Noort WA; Bril-Bazuin C; Benner R; Savelkoul HF
Bone Marrow Transplant; 1994 Mar; 13(3):293-301. PubMed ID: 8199571
[TBL] [Abstract][Full Text] [Related]
16. T lymphocyte responses in CVB3-induced murine myocarditis.
Huber S; Polgar J; Moraska A; Cunningham M; Schwimmbeck P; Schultheiss P
Scand J Infect Dis Suppl; 1993; 88():67-78. PubMed ID: 7685923
[TBL] [Abstract][Full Text] [Related]
17. Gamma delta T cells in the pathobiology of murine acute graft-versus-host disease. Evidence that gamma delta T cells mediate natural killer-like cytotoxicity in the host and that elimination of these cells from donors significantly reduces mortality.
Ellison CA; MacDonald GC; Rector ES; Gartner JG
J Immunol; 1995 Nov; 155(9):4189-98. PubMed ID: 7594574
[TBL] [Abstract][Full Text] [Related]
18. Triggering of the cytotoxic activity of murine natural killer and lymphokine-activated killer cells through the NK2.1 antigen.
Morelli L; Lemieux S
J Immunol; 1993 Dec; 151(12):6783-93. PubMed ID: 8258690
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 2 gene therapy of surgical minimal residual tumour disease: characterization of cytolytic effector cells from tumour progressors and regressors.
Hájková R; Indrová M; Jandlová T; Bubeník J; Reinis M
Folia Biol (Praha); 1999; 45(6):227-31. PubMed ID: 10732718
[TBL] [Abstract][Full Text] [Related]
20. Similar immune response to nonlethal infection with herpes simplex virus-1 in sensitive (BALB/c) and resistant (C57BL/6) strains of mice.
Brenner GJ; Cohen N; Moynihan JA
Cell Immunol; 1994 Sep; 157(2):510-24. PubMed ID: 8069930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
